ALEXANDER SWAN: Open Payments
NPI 1346218856 · AVENEL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,323 in 338 payments from 31 companies in 2025. Trend: 2023 $37,900 · 2024 $19,310 · 2025 $8,323
Food & beverage: $5,150Speaker / faculty: $3,050Education: $87Travel & lodging: $35
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 59 | $2,973 |
| Amgen Inc. | 72 | $1,803 |
| AstraZeneca Pharmaceuticals LP | 34 | $929 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 25 | $347 |
| Calliditas Therapeutics US Inc. | 4 | $262 |
| ANI Pharmaceuticals, Inc. | 31 | $256 |
| Phathom Pharmaceuticals, Inc. | 12 | $236 |
| Teva Pharmaceuticals USA, Inc. | 11 | $224 |
| Axsome Therapeutics, Inc. | 16 | $210 |
| Otsuka America Pharmaceutical, Inc. | 19 | $199 |
Products named: VRAYLAR, REPATHA, KRYSTEXXA, FARXIGA, XIFAXAN, TARPEYO, PURIFIED CORTROPHIN GEL, BREZTRI.
Industry payments across NJ — which companies pay providers there.
